All Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cancer, Nerouology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers' and Babies Health. Clinical trials are an essential component of helathcare. They provide the evidence to evaluate the safety and efficacy of new treantments and diagnositics, and provide alternative treatment options for patients with unmet needs.
Do you have ERpositive/HER2-negative early breast cancer?
Do you have ERpositive/HER2-negative early breast cancer?
A drug comparison for patients with newly diagnosed with metastatic hormone-sensitive prostate cancer
The purpose of this study is to compare the effects, good or bad of an investigational product, capivasertib added to standard treatments in patients who are newly diagnosed with metastatic hormone-sensitive prostate cancer (mHSPC) and your cancer has low levels of a protein called PTEN (or “PTEN deficiency”).
CB03: add-on therapy for focal epilepsy
A new treatment for Eosinophilic Esophagitis
A study of the safety and effectiveness of tezepelumab in adolescent and adult participants with Eosinophilic Esophagitis
Seeking cancer patients with nerve pain
Duloxetine versus pregabalin to treat opioid-resistant nerve pain in cancer patients.
Assessing the effectiveness of DB-1303 in the treatment of HER2-low breast cancer
The purpose of this trial is to assess the effectiveness of DB-1303 in the treatment of hormone receptor positive, HER2-low breast cancer, compared to standard of care.
Do you have Metastatic ER+/HER2− Breast Cancer with an ESR1 Mutation?
An Open Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for the Treatment of Pre- and Postmenopausal Women and Men with Locally Advanced or Metastatic ER+/HER2− Breast Cancer with an ESR1 Mutation.
ElevAAte - New Treatment for Adults with Alpha-1 Antitrypsin Deficiency (AATD) Emphysems
Study to compare INBRX-101 to plasma derived A1PI therapy in adults with AATD Emphysema
EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial – 1)
FAME 1 Eye research study - A new treatment for retinopathy in type 1 diabetes
Testing the safety and effectiveness of Fenofibrate in reducing diabetic retinopathy in adults with Type 1 diabetes